经尿道刀口变向钬激光前列腺剜除术与经尿道双极等离子前列腺剜除术治疗良性前列腺增生的疗效比较

目的 比较经尿道刀口变向钬激光前列腺剜除术(THoLEP)与经尿道双极等离子前列腺剜除术(PKERP)治疗良性前列腺增生(BPH)的疗效.方法 回顾性分析2016年9月至2018年9月收治的80例BPH患者,分为THoLEP组和PKERP组,对比分析两组患者的围手术期指标(手术时间、前列腺切除质量、术前后血红蛋白减少量...

Comparison of efficacy between turning holmium laser enucleation of the prostate and transurethral bipolar plasmakinetic enucleation and resection of the prostate in the treatment of benign prostatic hyperplasia

Objective To compare the clinical efficacy btHween turning holmium laser enucleation of the prostate(THoLEP)and transurethral bipolar plasmakinetic enucleation and resection of the prostate(PKERP)in the treatment of benign prostatic hyperplasia(BPH).Methods A retrospective analysis of 80 patients who were diagnosed BPH were divided into THoLEP group and PKERP group.The perioperative(operation time,gland weight,hemoglobin loss,bladder irrigation time,catheter indwelling time,time of hospital stay,surgical complications)and postoperative indexes[international prostate symptom score(IPSS),quality of life score(QOL),maximal urinary flow rate(Qniax),residual urine volume(RUV)and postoperative urinary incontinence]after 3 months were recorded and analyzed.Results There were no significance differences in preoperative factors between the two groups(P>0.05).The operation time(62.60±11.36)min,hemoglobin loss(9.87±6.56)g/L,the mean bladder irrigating time(18.5±4.2)h,catheter indwelling time(48.0±3.6)h,hand hospital stay time(5.89±1.25)days in THoLEP were shorter or less than those in PKERP(P<0.05).After 3 m onths,PV R,IPSS,Q max and QOL were both significantly improved(P<0.05),but the differences between the two groups were not significant(P>0.05).There were no complications such as perforation,massive hemorrhage and water poisoning in both groups.The postoperative urinary incontinence in THoLEP were less than those in PKERP(P>0.05).Conclusions THoLEP and PKERP have the same curative effect in the treatment of BPH,but the former is more security with fewer complications.THoLEP is worthy of widely application.